Medclair AB
Medclair AB is a Swedish cleantech firm that builds catalytic decomposition systems and exposure monitors to convert medical and industrial nitrous oxide emissions into harmless nitrogen and oxygen. The company serves hospitals, dental clinics, recycling facilities, and industrial N2O users globally via direct sales and distributors.
- Company typePublic
- Founded2013
- HeadquartersStockholm, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Medclair AB does
Medclair AB is a Swedish cleantech company, founded in 2013 in Borlänge and now headquartered in Stockholm, that specializes in the capture and catalytic decomposition of Nitrous Oxide (N2O) into harmless Nitrogen (N2) and Oxygen (O2). The company targets the climate and occupational risks of N2O — a gas with 273-298x the global warming potential of CO2 — across four sectors: hospitals and maternity wards (anesthesia and pain management), dental clinics (sedation), recycling and waste-management facilities (discarded N2O canisters), and industrial N2O users. Its product portfolio comprises the Mobile Destruction Unit (MDU, >99% destruction rate), the Central Destruction Unit (CDU, >95% purification across multiple treatment rooms), the Recycling Decomposition Unit (RDU, for canister disposal at waste sites), and the EXPO.p / NOD exposure monitors for workplace safety, with an integrated heat-exchanger design that reduces energy consumption after initial heating.
The core technology is a proprietary catalytic process operating at high temperature, validated by IVL Swedish Environmental Research Institute, and protected through know-how rather than a published patent portfolio. The company monetizes primarily through one-time capital-equipment sales of MDU, CDU, and RDU units, supplemented by monitoring hardware (EXPO.p, NOD) and a recurring service and support contract layer for maintenance, spare parts, and technical assistance. Pricing is quote-based and tailored to facility requirements, with multi-year enterprise contracts sold through a direct sales team and an international distributor network across more than 20 countries.
Medclair was listed on the NGM Nordic SME stock exchange in 2017 and operates as an independent Swedish firm under CEO Jonas Lundh, with co-founder Jerker Sundling as CTO and Olesya Nikonova as Chief R&D Officer. It reports 150+ hospital installations globally and flagship enterprise accounts including Hvidovre Hospital (Denmark), Royal Victoria Infirmary (UK NHS), Eastman Institute (Sweden), SUEZ, and Veolia. Leadership has publicly articulated a tenfold growth ambition, supported by recent expansion into the recycling vertical via the RDU and a global destruction capacity of approximately 492,000 tonnes CO2e in 2025.
Medclair AB firmographics
Firmographics- Name
- Medclair AB
- Legal name
- Medclair AB
- Website
- https://medclair.com
- Company type
- Public
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medclair AB is a Swedish cleantech firm that builds catalytic decomposition systems and exposure monitors to convert medical and industrial nitrous oxide emissions into harmless nitrogen and oxygen. The company serves hospitals, dental clinics, recycling facilities, and industrial N2O users globally via direct sales and distributors.
- Ownership category
- akta.pro rank
Medclair AB industry classification
Industry- Product category
- Emission Control Equipment
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- akta.pro primary industry
- Emission Control & Scrubbing Equipment (Scrubbers, Dust Collectors, Catalytic Systems) (IMAHAEAK)
- akta.pro secondary industry
- Airborne Chemical Exposure Monitoring (VOCs, Solvents, Gases) (EUAHAGAA)
Keywords
Where Medclair AB is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
Medclair AB business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Hardware Sales - Destruction Units: Medclair generates revenue primarily through the sale of N2O destruction hardware systems including Mobile Destruction Units (MDU), Central Destruction Units (CDU), and Recycling Decomposition Units (RDU). These are capital equipment purchases for healthcare facilities, dental clinics, and recycling stations.
- Monitoring Equipment Sales: Sale of EXPO.p exposure monitors and NOD (Nitrous Oxide Detector) devices for workplace safety monitoring in healthcare and industrial settings.
- Service and Support: Full service commitment and ongoing support for customers, including maintenance, spare parts, and technical assistance for installed systems.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing via direct sales |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Medclair AB product offering
Product offeringCore offering
Medclair designs, manufactures, and sells catalytic Nitrous Oxide (N2O) destruction units and exposure monitors that capture and decompose N2O emissions into harmless Nitrogen and Oxygen. The portfolio includes the Mobile Destruction Unit (MDU), Central Destruction Unit (CDU), Recycling Decomposition Unit (RDU), and EXPO.p exposure monitor, sold primarily to hospitals, dental clinics, and recycling operators.
Product overview
Medclair AB offers a suite of Safe and Sustainable Nitrous Oxide (N2O) management systems designed to capture and decompose N2O into harmless Nitrogen and Oxygen. The product portfolio includes four core offerings: the Mobile Destruction Unit (MDU) for mobile healthcare use, the Central Destruction Unit (CDU) for centralized multi-room hospital installations, the EXPO.p for workplace N2O exposure monitoring with real-time alarms and data logging, and the Recycling Decomposition Unit (RDU) for safe handling of N2O canisters at recycling facilities. These systems work together to address the complete chain of safe and sustainable N2O use across healthcare, dentistry, and recycling sectors, protecting both people and the environment from the harmful effects of N2O emissions.
Differentiator
Problem solved
Functional benefit
Brands
- EXPO.p: Next-generation N2O exposure monitor with real-time alarms, personal logging, and reliable warning system for workplace safety.
- MDU (Mobile Destruction Unit)
- CDU (Central Destruction Unit)
- RDU (Recycling Decomposition Unit)
Products and services
- Mobile Destruction Unit (MDU) A mobile N2O destruction unit for healthcare settings that captures exhaled Nitrous Oxide from patients via connected masks or mouthpieces and decomposes it catalytically into Nitrogen and Oxygen, transforming above 99% of N2O. Features integrated monitoring and automatic shutdown protection and can be relocated between treatment rooms.
- Central Destruction Unit (CDU) A centralized N2O destruction system designed to manage emissions from multiple treatment rooms simultaneously, using a catalytic process to purify over 95% of Nitrous Oxide into harmless Nitrogen and Oxygen. Includes real-time emission monitoring and an energy-recycling technique that minimizes consumption.
- EXPO.p Nitrous Oxide Exposure Monitor A next-generation N2O workplace exposure monitor using advanced infrared sensor technology to measure gas absorption, providing real-time visual and audio alarms when exposure thresholds are exceeded and personal logging of exposure data. Compact and durable for all-day wear in healthcare and industrial environments.
- Recycling Decomposition Unit (RDU) A self-supporting N2O decomposition system for recycling facilities that collects Nitrous Oxide from discarded canisters and catalytically decomposes over 99% of incoming N2O with minimal energy consumption and low noise. The standard model decomposes 360g of N2O per hour and attaches to a wagon with capacity for 26 connected canisters.
Quantifiable outcome
- Over 99% N2O elimination rate for Mobile and Recycling Destruction Units
- +3 more outcomes
Companies that use Medclair AB
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Medclair AB technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature4 records
Medclair AB partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered flagship and core.
- SUEZflagshipUnique partnership between SUEZ, French local authorities, and Medclair that utilizes innovative gas destruction technology to eliminate industrial and environmental risks of discarded nitrous oxide canisters at recycling facilities.
- VeoliaflagshipVeolia, a major environmental services company, partnered with Medclair to become the first in the UK to introduce a safe and sustainable method for processing nitrous oxide canisters at recycling facilities.
- Grønnköpingkið University Hospital (World's Greenest Hospital)coreMedclair's solutions are featured as part of Grønnköpingkið University Hospital, which claims to be the World's Greenest Hospital initiative, demonstrating the company's integration into flagship sustainable healthcare projects.
- Nordic Centre for Sustainable HealthcarecoreMedclair is a member of the Nordic Centre for Sustainable Healthcare, a network promoting sustainable healthcare solutions across the Nordic region.
- SwecarecoreMedclair is a member of Swecare, a Swedish healthcare industry association supporting internationalization and networking for Swedish healthcare companies.
- IVL Swedish Environmental Research InstitutecoreThird-party validation of Mobile Destruction Unit conducted by IVL Swedish Environmental Research Institute, providing independent scientific verification of destruction efficiency claims.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Medclair AB competitors and assessment
Company assessmentEmerging players
- Chart Industries: Chart Industries manufactures cryogenic and gas processing equipment for industrial, medical, and energy applications, including specialty gas handling. Comparable because Chart operates in the gas processing equipment space that overlaps with Medclair's catalytic decomposition technology.
Direct peers
- Drägerwerk: Drägerwerk is a German medical and safety technology company that manufactures anesthesia delivery systems, patient monitoring, and gas detection equipment for hospitals. Comparable to Medclair because both serve the same clinical and workplace safety use cases around inhaled anesthetics and N2O in hospitals.
- Mindray: Mindray is a Chinese medical device manufacturer that produces anesthesia machines, patient monitors, and related equipment for global hospital markets. Comparable because Mindray competes with Medclair's healthcare customers on adjacent anesthesia and monitoring product categories.
- Penlon: Penlon is a UK-based manufacturer of anesthesia delivery systems and related medical gas equipment used in hospitals. Comparable because Penlon targets the same anesthesia and gas management workflow Medclair addresses, and is a closer geographic and scale peer than the global anesthesia majors.
Broad incumbents
- GE HealthCare: GE HealthCare manufactures anesthesia delivery machines and patient monitoring systems used in hospitals worldwide. Comparable because both companies serve hospital anesthesia and perioperative workflows, though GE HealthCare operates across a much broader portfolio.
- Linde plc: Linde is one of the world's largest industrial gas suppliers, including N2O for medical and food service applications. Comparable because Linde controls the supply side of N2O and has the customer relationships and balance sheet to enter downstream destruction or recovery.
- Baxter International: Baxter is a large medical products and pharmaceuticals company that supplies N2O for anesthesia as part of its medical gases portfolio. Comparable because Baxter sits at the supply side of the same N2O value chain Medclair addresses at the destruction and monitoring end.
- Air Liquide: Air Liquide is a global industrial and medical gas supplier, including N2O products for healthcare and other industries. Comparable because Air Liquide sells N2O into the same hospital customer base Medclair serves on the destruction side.
Regional players
- Stericycle: Stericycle is a US-focused regulated waste management company providing medical and hazardous waste collection and disposal services. Comparable because Stericycle addresses regulated medical and industrial waste streams that overlap with Medclair's RDU canister handling use case, but primarily serves North America.
Others
- Parker Hannifin: Parker Hannifin manufactures motion and control technologies, including gas filtration, separation, and analytical instruments used in industrial and emissions applications. Comparable as an enabling technology provider adjacent to Medclair's gas processing and monitoring solutions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Medclair AB social profiles
Digital presenceMedclair AB financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medclair AB leadership team
Management profileNumber of profiles
Profiles4 records
Medclair AB funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medclair AB M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medclair AB
What does Medclair AB do?
Medclair designs, manufactures, and sells catalytic Nitrous Oxide (N2O) destruction units and exposure monitors that capture and decompose N2O emissions into harmless Nitrogen and Oxygen. The portfolio includes the Mobile Destruction Unit (MDU), Central Destruction Unit (CDU), Recycling Decomposition Unit (RDU), and EXPO.p exposure monitor, sold primarily to hospitals, dental clinics, and recycling operators.
Is Medclair AB a public or private company?
Medclair AB is a public company. It is classified as public and is currently operating.
When was Medclair AB founded?
Medclair AB was founded in 2013. It employs 11 to 50 people.
Where is Medclair AB based?
Medclair AB is headquartered in Stockholm, Sweden, in the Europe region.
How does Medclair AB make money?
Three revenue lines are on record. Hardware Sales - Destruction Units are the primary driver. The others are monitoring Equipment Sales and service and Support.
Who are Medclair AB's main competitors?
Chart Industries is listed as an emerging player. Direct peers are Drägerwerk, Mindray and Penlon. Broad incumbents are GE HealthCare, Linde plc, Baxter International and Air Liquide. Stericycle is listed as a regional player. Parker Hannifin is listed as an others.
Does Medclair AB have an API?
No public API is recorded for Medclair AB.
What industry is Medclair AB in?
Medclair AB's product category is Emission Control Equipment. Its primary akta.pro industry code is IMAHAEAK, Emission Control & Scrubbing Equipment (Scrubbers, Dust Collectors, Catalytic Systems), with a secondary code of EUAHAGAA, Airborne Chemical Exposure Monitoring (VOCs, Solvents, Gases). Its NAICS code is 3345.